Resumen de Gobernanza de riesgos de la nanomedicina: el caso europeo

Joseba Andoni Ibarra Unzueta, Hannot Rodríguez Zabaleta

• Nanomedicine is the application of nanotechnology to the study and improvement of human health, and a research area of high economic significance as well. But it also implies risks for human health and the environment, so the European Union claims to be committed to its “responsible development”. However, there are different opinions in the EU about how nanomedicine—and nanotechnology in general—should be regulated. This paper will analyze critically two of the more relevant opinions.